Tracy Onega, PhD, MPAS

Academic Information

  • Departments: Population Health Sciences - Professor
  • Divisions: Cancer Population Science

Academic Office Information

  • 801-646-4061
  • Huntsman Cancer Hospital
    1950 Circle of Hope, Room: 4725
    Salt Lake City, UT 84112

Academic Bio

Jon M. and Karen Huntsman Presidential Professor in Cancer Research
Senior Director, Population Sciences

Professor, Department of Population Health Sciences, University of Utah

A cancer epidemiologist and health services researcher, Onega’s research focuses on cancer control, including health information technology, cancer care delivery to rural populations, comparative effectiveness, and precision oncology. Onega serves as principal investigator of several National Cancer Institute (NCI) and Patient-Centered Outcomes Research Institute (PCORI) grants studying breast cancer screening and surveillance and novel approaches for access to, and evaluation of, cancer care. She has published more than 180 articles.

Onega previously served as associate director of Community Outreach and Engagement and co-leader of the Cancer Population Sciences Program at Dartmouth’s Norris Cotton Cancer Center, a National Cancer Institute-Designated Comprehensive Cancer Center. She was also director of the Division of Biomedical Informatics and director of the New Hampshire Mammography Network. Onega served as a professor of biomedical data science and epidemiology in the Dartmouth Institute for Health Policy and Clinical Practice at the Geisel School of Medicine at Dartmouth.

Onega earned her PhD from Dartmouth College in evaluative clinical sciences and clinical epidemiology. She received a master of science in health informatics from Northeastern University and a master of arts in geography from the University of Vermont. She received her master of physician assistant studies from the University of Iowa and served as a physician assistant in primary care.

Education History

Type School Degree
Graduate Training Northeastern University
Health Informatics
M.S.
Post Graduate Training Dartmouth Medical School
Evaluative Clinical Sciences/Clinical Epidemiology
Ph.D.
Graduate Training University of Iowa College of Medicine
Physician Assistant Program
M.P.A.S.
Graduate Training University of Vermont
Geography - Geographic Information Systems
M.A.
Undergraduate Vanderbilt University
Biology
B.S.

Selected Publications

Journal Article

  1. Demb J, Abraham L, Miglioretti DL, Sprague BL, OMeara ES, Advani S, Henderson LM, Onega T, Buist DSM, Schousboe JT, Walter LC, Kerlikowske K, Braithwaite D, Breast Cancer Surveillance Consortium (2019). Screening Mammography Outcomes: Risk of Breast Cancer and Mortality by Comorbidity Score and Age. J Natl Cancer Inst, 112(6), 599-606.
  2. Onega T, Weiss JE, Alford-Teaster J, Goodrich M, Eliassen MS, Kim SJ (2019). Concordance of Rural-Urban Self-identity and ZIP Code-Derived Rural-Urban Commuting Area (RUCA) Designation. J Rural Health, 36(2), 274-280.
  3. Barlow WE, Beaber EF, Geller BM, Kamineni A, Zheng Y, Haas JS, Chao CR, Rutter CM, Zauber AG, Sprague BL, Halm EA, Weaver DL, Chubak J, Doria-Rose VP, Kobrin S, Onega T, Quinn VP, Schapira MM, Tosteson ANA, Corley DA, Skinner CS, Schnall MD, Armstrong K, Wheeler CM, Silverberg MJ, Balasubramanian BA, Doubeni CA, McLerran D, Tiro JA (2018). Evaluating Screening Participation, Follow-up, and Outcomes for Breast, Cervical, and Colorectal Cancer in the PROSPR Consortium. J Natl Cancer Inst, 112(3), 238-246.
  4. Piepkorn MW, Longton GM, Reisch LM, Elder DE, Pepe MS, Kerr KF, Tosteson ANA, Nelson HD, Knezevich S, Radick A, Shucard H, Onega T, Carney PA, Elmore JG, Barnhill RL (2019). Assessment of Second-Opinion Strategies for Diagnoses of Cutaneous Melanocytic Lesions. JAMA Netw Open, 2(10), e1912597.
  5. Henderson LM, Ichikawa L, Buist DSM, Lee JM, Bush M, Johnson D, Onega T, Nekhlyudov L, Kerlikowske K, Miglioretti DL, Sprague BL, Wernli KJ (2019). Patterns of Breast Imaging Use Among Women with a Personal History of Breast Cancer. J Gen Intern Med, 34(10), 2098-2106.
  6. Beaber EF, Sprague BL, Tosteson ANA, Haas JS, Onega T, Schapira MM, McCarthy AM, Li CI, Herschorn SD, Lehman CD, Wernli KJ, Barlow WE (2018). Multilevel Predictors of Continued Adherence to Breast Cancer Screening Among Women Ages 50-74 Years in a Screening Population. J Womens Health (Larchmt), 28(8), 1051-1059.
  7. Wernli KJ, Ichikawa L, Kerlikowske K, Buist DSM, Brandzel SD, Bush M, Johnson D, Henderson LM, Nekhlyudov L, Onega T, Sprague BL, Lee JM, Lehman CD, Miglioretti DL (2019). Surveillance Breast MRI and Mammography: Comparison in Women with a Personal History of Breast Cancer. Radiology, 292(2), 311-318.
  8. Palmer EL, Hassanpour S, Higgins J, Doherty JA, Onega T (2019). Building a tobacco user registry by extracting multiple smoking behaviors from clinical notes. BMC Med Informat Decis Making, 19(1), 141.
  9. Palmer EL, Higgins J, Hassanpour S, Sargent J, Robinson CM, Doherty JA, Onega T (2019). Assessing data availability and quality within an electronic health record system through external validation against an external clinical data source. BMC Med Informat Decis Making, 19(1), 143.
  10. Kerlikowske K, Sprague BL, Tosteson ANA, Wernli KJ, Rauscher GH, Johnson D, Buist DSM, Onega T, Henderson LM, OMeara ES, Miglioretti DL (2019). Strategies to Identify Women at High Risk of Advanced Breast Cancer During Routine Screening for Discussion of Supplemental Imaging. (Epub ahead of print) JAMA Intern Med.
  11. Conant EF, Barlow WE, Herschorn SD, Weaver DL, Beaber EF, Tosteson ANA, Haas JS, Lowry KP, Stout NK, Trentham-Dietz A, diFlorio-Alexander RM, Li CI, Schnall MD, Onega T, Sprague BL, Population-based Research Optimizing Screening Through Personalized Regimen PROSPR Consortium (2019). Association of Digital Breast Tomosynthesis vs Digital Mammography With Cancer Detection and Recall Rates by Age and Breast Density. JAMA Oncol, 5(5), 635-642.
  12. Arasu VA, Miglioretti DL, Sprague BL, Alsheik NH, Buist DSM, Henderson LM, Herschorn SD, Lee JM, Onega T, Rauscher GH, Wernli KJ, Lehman CD, Kerlikowske K (2019). Population-Based Assessment of the Association Between Magnetic Resonance Imaging Background Parenchymal Enhancement and Future Primary Breast Cancer Risk. J Clin Oncol, 37(12), 954-963.
  13. MacKenzie TA, Houle J, Jiang S, Onega T (2019). Middle-aged death and taxes in the USA: Association of state tax burden and expenditures in 2005 with survival from 2006 to 2015. PLoS ONE, 14(4), e0214463.
  14. Davidson TM, Rendi MH, Frederick PD, Onega T, Allison KH, Mercan E, Bruny TT, Shapiro LG, Weaver DL, Elmore JG (2019). Breast Cancer Prognostic Factors in the Digital Era: Comparison of Nottingham Grade using Whole Slide Images and Glass Slides. J Pathol Inform, 10, 11.
  15. Austin AM, Kapadia NS, Brooks GA, Onega TL, Eliassen AH, Tamimi RM, Holmes M, Wang Q, Grodstein F, Tosteson ANA (2019). Comparison of treatment of early-stage breast cancer among Nurses' Health Study participants and other Medicare beneficiaries. Breast Cancer Res Treat, 174(3), 759-767.
  16. Moen EL, Kapadia NS, OMalley AJ, Onega T (2018). Evaluating Breast Cancer Care Coordination at a Rural National Cancer Institute Comprehensive Cancer Center Using Network Analysis and Geospatial Methods. Cancer Epidemiol Biomarkers Prev, 28(3), 455-461.
  17. Ung MH, MacKenzie TA, Onega TL, Amos CI, Cheng C (2018). Statins associate with improved mortality among patients with certain histological subtypes of lung cancer. Lung Cancer, 126, 89-96.
  18. Onega T, Kamra D, Alford-Teaster J, Hassanpour S (2019). Monitoring of Technology Adoption Using Web Content Mining of Location Information and Geographic Information Systems: A Case Study of Digital Breast Tomosynthesis. JCO Clin Cancer Inform, 2, 1-10.
  19. Onega T, Barnhill RL, Piepkorn MW, Longton GM, Elder DE, Weinstock MA, Knezevich SR, Reisch LM, Carney PA, Nelson HD, Radick AC, Elmore JG (2018). Accuracy of Digital Pathologic Analysis vs Traditional Microscopy in the Interpretation of Melanocytic Lesions. JAMA Dermatol, 154(10), 1159-1166.
  20. diFlorio Alexander RM, Haider SJ, MacKenzie T, Goodrich ME, Weiss J, Onega T (2018). Correlation between obesity and fat-infiltrated axillary lymph nodes visualized on mammography. Br J Radiol, 91(1089), 20170110.
  21. Schapira MM, Barlow WE, Conant EF, Sprague BL, Tosteson ANA, Haas JS, Onega T, Beaber EF, Goodrich M, McCarthy AM, Herschorn SD, Skinner CS, Harrington TO, Geller B (2018). Communication Practices of Mammography Facilities and Timely Follow-up of a Screening Mammogram with a BI-RADS 0 Assessment. Acad Radiol, 25(9), 1118-1127.
  22. Henderson LM, Hubbard RA, Zhu W, Weiss J, Wernli KJ, Goodrich ME, Kerlikowske K, DeMartini W, Ozanne EM, Onega T (2018). Preoperative Breast Magnetic Resonance Imaging Use by Breast Density and Family History of Breast Cancer. J Womens Health (Larchmt), 27(8), 987-993.
  23. Chowdhury M, Euhus D, ODonnell M, Onega T, Choudhary PK, Biswas S (2018). Dose-dependent effect of mammographic breast density on the risk of contralateral breast cancer. Breast Cancer Res Treat, 170(1), 143-148.
  24. Onega T, Zhu W, Weiss JE, Goodrich M, Tosteson ANA, DeMartini W, Virnig BA, Henderson LM, Buist DSM, Wernli KJ, Kerlikowske K, Hubbard RA (2018). Preoperative breast MRI and mortality in older women with breast cancer. Breast Cancer Res Treat, 170(1), 149-157.
  25. Elder DE, Piepkorn MW, Barnhill RL, Longton GM, Nelson HD, Knezevich SR, Pepe MS, Carney PA, Titus LJ, Onega T, Tosteson ANA, Weinstock MA, Elmore JG (2018). Pathologist characteristics associated with accuracy and reproducibility of melanocytic skin lesion interpretation. J Am Acad Dermatol, 79(1), 52-59.e5.
  26. Miles R, Wan F, Onega TL, Lenderink-Carpenter A, OMeara ES, Zhu W, Henderson LM, Haas JS, Hill DA, Tosteson ANA, Wernli KJ, Alford-Teaster J, Lee JM, Lehman CD, Lee CI (2018). Underutilization of Supplemental Magnetic Resonance Imaging Screening Among Patients at High Breast Cancer Risk. J Womens Health (Larchmt), 27(6), 748-754.
  27. Nutter EL, Weiss JE, Marotti JD, Barth RJ Jr, Eliassen MS, Goodrich ME, Petersen CL, Onega T (2017). Personal history of proliferative breast disease with atypia and risk of multifocal breast cancer. Cancer, 124(7), 1350-1357.
  28. Buist DSM, Abraham L, Lee CI, Lee JM, Lehman C, OMeara ES, Stout NK, Henderson LM, Hill D, Wernli KJ, Haas JS, Tosteson ANA, Kerlikowske K, Onega T, Breast Cancer Surveillance Consortium (2018). Breast Biopsy Intensity and Findings Following Breast Cancer Screening in Women With and Without a Personal History of Breast Cancer. JAMA Intern Med, 178(4), 458-468.
  29. Braithwaite D, Miglioretti DL, Zhu W, Demb J, Trentham-Dietz A, Sprague B, Tice JA, Onega T, Henderson LM, Buist DSM, Ziv E, Walter LC, Kerlikowske K, Breast Cancer Surveillance Consortium (2018). Family History and Breast Cancer Risk Among Older Women in the Breast Cancer Surveillance Consortium Cohort. JAMA Intern Med, 178(4), 494-501.
  30. Hill DA, Haas JS, Wellman R, Hubbard RA, Lee CI, Alford-Teaster J, Wernli KJ, Henderson LM, Stout NK, Tosteson ANA, Kerlikowske K, Onega T (2017). Utilization of breast cancer screening with magnetic resonance imaging in community practice. J Gen Intern Med, 33(3), 275-283.
  31. Geller BM, Frederick PD, Knezevich SR, Lott JP, Nelson HD, Titus LJ, Carney PA, Tosteson ANA, Onega TL, Barnhill RL, Weinstock MA, Elder DE, Piepkorn MW, Elmore JG (2017). Pathologists' Use of Second Opinions in Interpretation of Melanocytic Cutaneous Lesions: Policies, Practices, and Perceptions. Dermatol Surg, 44(2), 177-185.
  32. Tosteson ANA, Yang Q, Nelson HD, Longton G, Soneji SS, Pepe M, Geller B, Carney PA, Onega T, Allison KH, Elmore JG, Weaver DL (2017). Second opinion strategies in breast pathology: a decision analysis addressing over-treatment, under-treatment, and care costs. Breast Cancer Res Treat, 167(1), 195-203.
  33. Chubak J, Onega T, Zhu W, Buist DSM, Hubbard RA (2017). An Electronic Health Record-based Algorithm to Ascertain the Date of Second Breast Cancer Events. Med Care, 55(12), e81-e87.
  34. Xu Y, Fu C, Onega T, Shi X, Wang F (2017). Disparities in Geographic Accessibility of National Cancer Institute Cancer Centers in the United States. J Med Syst, 41(12), 203.
  35. Miglioretti DL, Ichikawa L, Smith RA, Buist DSM, Carney PA, Geller B, Monsees B, Onega T, Rosenberg R, Sickles EA, Yankaskas BC, Kerlikowske K (2017). Correlation Between Screening Mammography Interpretive Performance on a Test Set and Performance in Clinical Practice. Acad Radiol, 24(10), 1256-1264.
  36. Raffin E, Onega T, Bynum J, Austin A, Carmichael D, Bronner K, Goodney P, Hyams ES (2017). Are there regional tendencies toward controversial screening practices? A study of prostate and breast cancer screening in a Medicare population. Cancer Epidemiol, 50(Pt A), 68-75.
  37. Lott JP, Wang Q, Titus LJ, Onega T, Nelson HD, Weinstock MA, Elmore JG, Tosteson ANA (2017). Temporal trends in healthcare utilization following primary melanoma diagnosis among Medicare beneficiaries. Br J Dermatol, 177(3), 845-853.
  38. Onega T, Alford-Teaster J, Wang F (2017). Population-based geographic access to parent and satellite National Cancer Institute Cancer Center Facilities. Cancer, 123(17), 3305-3311.
  39. Buist DSM, Gao H, Anderson ML, Onega T, Brandzel S, Rabelhofer MA, Bradford SC, Aiello Bowles EJ (2017). Breast cancer screening outreach effectiveness: Mammogram-specific reminders vs. comprehensive preventive services birthday letters. Prev Med, 102, 49-58.
  40. Wernli KJ, Arao RF, Hubbard RA, Sprague BL, Alford-Teaster J, Haas JS, Henderson L, Hill D, Lee CI, Tosteson ANA, Onega T (2017). Change in Breast Cancer Screening Intervals Since the 2009 USPSTF Guideline. J Womens Health (Larchmt), 26(8), 820-827.
  41. Chen Y, Marotti JD, Jenson EG, Onega TL, Johnson KC, Christensen BC (2017). Concordance of DNA methylation profiles between breast core biopsy and surgical excision specimens containing ductal carcinoma in situ (DCIS). Exp Mol Pathol, 103(1), 78-83.
  42. Onega T, Weaver DL, Frederick PD, Allison KH, Tosteson ANA, Carney PA, Geller BM, Longton GM, Nelson HD, Oster NV, Pepe MS, Elmore JG (2017). The diagnostic challenge of low-grade ductal carcinoma in situ. Eur J Cancer, 80, 39-47.
  43. Elmore JG, Barnhill RL, Elder DE, Longton GM, Pepe MS, Reisch LM, Carney PA, Titus LJ, Nelson HD, Onega T, Tosteson ANA, Weinstock MA, Knezevich SR, Piepkorn MW (2017). Pathologists' diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study. BMJ, 357, j2813.
  44. Jackson SL, Frederick PD, Pepe MS, Nelson HD, Weaver DL, Allison KH, Carney PA, Geller BM, Tosteson AN, Onega T, Elmore JG (2016). Diagnostic Reproducibility: What Happens When the Same Pathologist Interprets the Same Breast Biopsy Specimen at Two Points in Time? Ann Surg Oncol, 24(5), 1234-1241.
  45. Clark CR, Tosteson TD, Tosteson ANA, Onega T, Weiss JE, Harris KA, Haas JS (2017). Diffusion of digital breast tomosynthesis among women in primary care: associations with insurance type. Cancer Med, 6(5), 1102-1107.
  46. Weinstock MA, Lott JP, Wang Q, Titus LJ, Onega T, Nelson HD, Pearson L, Piepkorn M, Barnhill RL, Elmore JG, Tosteson ANA (2017). Skin biopsy utilization and melanoma incidence among Medicare beneficiaries. Br J Dermatol, 176(4), 949-954.
  47. Lehman CD, Arao RF, Sprague BL, Lee JM, Buist DS, Kerlikowske K, Henderson LM, Onega T, Tosteson AN, Rauscher GH, Miglioretti DL (2016). National Performance Benchmarks for Modern Screening Digital Mammography: Update from the Breast Cancer Surveillance Consortium. Radiology, 283(1), 49-58.
  48. Haas JS, Barlow WE, Schapira MM, MacLean CD, Klabunde CN, Sprague BL, Beaber EF, Chen JS, Bitton A, Onega T, Harris K, Tosteson ANA, PROSPR Population-based Research Optimizing Screening through Personalized Regimens consortium (2017). Primary Care Providers' Beliefs and Recommendations and Use of Screening Mammography by their Patients. J Gen Intern Med, 32(4), 449-457.
  49. Sprague BL, Arao RF, Miglioretti DL, Henderson LM, Buist DS, Onega T, Rauscher GH, Lee JM, Tosteson AN, Kerlikowske K, Lehman CD, Breast Cancer Surveillance Consortium (2017). National Performance Benchmarks for Modern Diagnostic Digital Mammography: Update from the Breast Cancer Surveillance Consortium. Radiology, 283(1), 59-69.
  50. Elmore JG, Longton GM, Pepe MS, Carney PA, Nelson HD, Allison KH, Geller BM, Onega T, Tosteson AN, Mercan E, Shapiro LG, Bruny TT, Morgan TR, Weaver DL (2017). A Randomized Study Comparing Digital Imaging to Traditional Glass Slide Microscopy for Breast Biopsy and Cancer Diagnosis. J Pathol Inform, 8, 12.
  51. Weiss JE, Goodrich M, Harris KA, Chicoine RE, Synnestvedt MB, Pyle SJ, Chen JS, Herschorn SD, Beaber EF, Haas JS, Tosteson AN, Onega T, PROSPR Population-based Research Optimizing Screening through Personalized Regimens consortium (2016). Challenges With Identifying Indication for Examination in Breast Imaging as a Key Clinical Attribute in Practice, Research, and Policy. J Am Coll Radiol, 14(2), 198-207.e2.
  52. Brandzel S, Rosenberg DE, Johnson D, Bush M, Kerlikowske K, Onega T, Henderson L, Nekhlyudov L, DeMartini W, Wernli KJ (2017). Women's experiences and preferences regarding breast imaging after completing breast cancer treatment. Patient Prefer Adherence, 11, 199-204.
  53. Ozanne EM, Weiss JE, Onega T, DeMartini W, Kerlikowske K, Buist DS, Henderson L, Hubbard RA, Goodrich M, Tosteson AN, Virnig BA, ODonoghue C (2016). Locoregional treatment of breast cancer in women with and without preoperative magnetic resonance imaging. Am J Surg, 213(1), 132-139.e2.
  54. Haas JS, Baer HJ, Eibensteiner K, Klinger EV, St Hubert S, Getty G, Brawarsky P, Orav EJ, Onega T, Tosteson AN, Bates DW, Colditz G (2016). A Cluster Randomized Trial of a Personalized Multi-Condition Risk Assessment in Primary Care. Am J Prev Med, 52(1), 100-105.
  55. Lee KC, Peacock S, Weinstock MA, Zhao GA, Knezevich SR, Elder DE, Barnhill RL, Piepkorn MW, Reisch LM, Carney PA, Onega T, Lott JP, Elmore JG (2016). Variation among pathologists' treatment suggestions for melanocytic lesions: A survey of pathologists. J Am Acad Dermatol, 76(1), 121-128.
  56. Chowdhury M, Euhus D, Onega T, Biswas S, Choudhary PK (2016). A model for individualized risk prediction of contralateral breast cancer. Breast Cancer Res Treat, 161(1), 153-160.
  57. Onega T, Haas JS, Bitton A, Brackett C, Weiss J, Goodrich M, Harris K, Pyle S, Tosteson AN (2017). Alignment of breast cancer screening guidelines, accountability metrics, and practice patterns. Am J Manag Care, 23(1), 35-40.
  58. Beaber EF, Tosteson AN, Haas JS, Onega T, Sprague BL, Weaver DL, McCarthy AM, Doubeni CA, Quinn VP, Skinner CS, Zauber AG, Barlow WE (2016). Breast cancer screening initiation after turning 40 years of age within the PROSPR consortium. Breast Cancer Res Treat, 160(2), 323-331.
  59. Onega T, Smith M, Miglioretti DL, Carney PA, Geller BA, Kerlikowske K, Buist DS, Rosenberg RD, Smith RA, Sickles EA, Haneuse S, Anderson ML, Yankaskas B (2016). Radiologist Agreement for Mammographic Recall by Case Difficulty and Finding Type. J Am Coll Radiol, 13(11S), e72-e79.
  60. Baughman AW, Brawarsky P, Onega T, Tosteson TD, Wang Q, Tosteson AN, Haas JS (2016). Medical home transformation and breast cancer screening. Am J Manag Care, 22(11), e382-e388.
  61. Sprague BL, Conant EF, Onega T, Garcia MP, Beaber EF, Herschorn SD, Lehman CD, Tosteson AN, Lacson R, Schnall MD, Kontos D, Haas JS, Weaver DL, Barlow WE, PROSPR Consortium (2016). Variation in Mammographic Breast Density Assessments Among Radiologists in Clinical Practice: A Multicenter Observational Study. Ann Intern Med, 165(7), 457-464.
  62. Schapira MM, Sprague BL, Klabunde CN, Tosteson AN, Bitton A, Chen JS, Beaber EF, Onega T, MacLean CD, Harris K, Howe K, Pearson L, Feldman S, Brawarsky P, Haas JS, PROSPR consortium (2016). Inadequate Systems to Support Breast and Cervical Cancer Screening in Primary Care Practice. J Gen Intern Med, 31(10), 1148-55.
  63. Chang CH, Bynum JP, Onega T, Colla CH, Lurie JD, Tosteson AN (2016). Screening Mammography Use Among Older Women Before and After the 2009 U.S. Preventive Services Task Force Recommendations. J Womens Health (Larchmt), 25(10), 1030-1037.
  64. Hubbard RA, OMeara ES, Henderson LM, Hill D, Braithwaite D, Haas JS, Lee CI, Sprague BL, Alford-Teaster J, Tosteson ANA, Wernli KJ, Onega T (2016). Multilevel factors associated with long-term adherence to screening mammography in older women in the U.S. Prev Med, 89, 169-177.
  65. Onega T, Weiss JE, Buist DS, Tosteson AN, Henderson LM, Kerlikowske K, Goodrich ME, ODonoghue C, Wernli KJ, DeMartini WB, Virnig BA, Bennette CS, Hubbard RA (2016). Breast MRI in the Diagnostic and Preoperative Workup Among Medicare Beneficiaries With Breast Cancer. Med Care, 54(7), 719-24.
  66. Zhao G, Lee KC, Kwon G, Frederick PD, Onega TL, Piepkorn MW, Knezevich S, Barnhill RL, Elder DE, Elmore JG (2016). The self-reported use of immunostains and cytogenetic testing in the diagnosis of melanoma by practicing U.S. pathologists of 10 selected states. J Cutan Pathol, 43(6), 492-7.
  67. Onega T, Lee CI, Benkeser D, Alford-Teaster J, Haas JS, Tosteson AN, Hill D, Shi X, Henderson LM, Hubbard RA (2016). Travel Burden to Breast MRI and Utilization: Are Risk and Sociodemographics Related? J Am Coll Radiol, 13(6), 611-9.
  68. Elmore JG, Nelson HD, Pepe MS, Longton GM, Tosteson AN, Geller B, Onega T, Carney PA, Jackson SL, Allison KH, Weaver DL (2016). Variability in Pathologists' Interpretations of Individual Breast Biopsy Slides: A Population Perspective. Ann Intern Med, 164(10), 649-55.
  69. Onega T, Reisch LM, Frederick PD, Geller BM, Nelson HD, Lott JP, Radick AC, Elder DE, Barnhill RL, Piepkorn MW, Elmore JG (2015). Use of Digital Whole Slide Imaging in Dermatopathology. J Digit Imaging, 29(2), 243-53.
  70. Kennedy LS, Bejarano SA, Onega TL, Stenquist DS, Chamberlin MD (2016). Opportunistic Breast Cancer Education and Screening in Rural Honduras. J Glob Oncol, 2(4), 174-180.
  71. Fenton JJ, Onega T, Zhu W, Balch S, Smith-Bindman R, Henderson L, Sprague BL, Kerlikowske K, Hubbard RA (2017). Validation of a Medicare Claims-based Algorithm for Identifying Breast Cancers Detected at Screening Mammography. Med Care, 54(3), e15-22.
  72. Lee CI, Bogart A, Germino JC, Goldman LE, Hubbard RA, Haas JS, Hill DA, Tosteson AN, Alford-Teaster JA, DeMartini WB, Lehman CD, Onega TL (2015). Availability of Advanced Breast Imaging at Screening Facilities Serving Vulnerable Populations. J Med Screen, 23(1), 24-30.
  73. Onega T, Goldman LE, Walker RL, Miglioretti DL, Buist DS, Taplin S, Geller BM, Hill DA, Smith-Bindman R (2015). Facility Mammography Volume in Relation to Breast Cancer Screening Outcomes. J Med Screen, 23(1), 31-7.
  74. Havidich JE, Beach M, Dierdorf SF, Onega T, Suresh G, Cravero JP (2016). Preterm Versus Term Children: Analysis of Sedation/Anesthesia Adverse Events and Longitudinal Risk. Pediatrics, 137(3), e20150463.
  75. Onega T, Tosteson AN, Weiss J, Alford-Teaster J, Hubbard RA, Henderson LM, Kerlikowske K, Goodrich ME, ODonoghue C, Wernli KJ, DeMartini WB, Virnig BA (2016). Costs of diagnostic and preoperative workup with and without breast MRI in older women with a breast cancer diagnosis. BMC Health Serv Res, 16, 76.
  76. Chen JS, Sprague BL, Klabunde CN, Tosteson AN, Bitton A, Onega T, MacLean CD, Harris K, Schapira MM, Haas JS, PROSPR Population-based Research Optimizing Screening through Personalized Regimens Consortium (2016). Take the money and run? Redemption of a gift card incentive in a clinician survey. BMC Med Res Methodol, 16, 25.
  77. Alford-Teaster J, Lange JM, Hubbard RA, Lee CI, Haas JS, Shi X, Carlos HA, Henderson L, Hill D, Tosteson AN, Onega T (2016). Is the closest facility the one actually used? An assessment of travel time estimation based on mammography facilities. Int J Health Geogr, 15, 8.
  78. Haas JS, Hill DA, Wellman RD, Hubbard RA, Lee CI, Wernli KJ, Stout NK, Tosteson AN, Henderson LM, Alford-Teaster JA, Onega TL (2015). Disparities in the use of screening magnetic resonance imaging of the breast in community practice by race, ethnicity, and socioeconomic status. Cancer, 122(4), 611-7.
  79. Conant EF, Beaber EF, Sprague BL, Herschorn SD, Weaver DL, Onega T, Tosteson AN, McCarthy AM, Poplack SP, Haas JS, Armstrong K, Schnall MD, Barlow WE (2016). Breast cancer screening using tomosynthesis in combination with digital mammography compared to digital mammography alone: a cohort study within the PROSPR consortium. Breast Cancer Res Treat, 156(1), 109-16.
  80. Haas JS, Sprague BL, Klabunde CN, Tosteson AN, Chen JS, Bitton A, Beaber EF, Onega T, Kim JJ, MacLean CD, Harris K, Yamartino P, Howe K, Pearson L, Feldman S, Brawarsky P, Schapira MM, PROSPR Population-based Research Optimizing Screening through Personalized Regimens Consortium (2015). Provider Attitudes and Screening Practices Following Changes in Breast and Cervical Cancer Screening Guidelines. J Gen Intern Med, 31(1), 52-9.
  81. Henderson LM, Weiss J, Hubbard RA, ODonoghue C, DeMartini WB, Buist DS, Kerlikowske K, Goodrich M, Virnig B, Tosteson AN, Lehman CD, Onega T (2015). Factors Associated with Preoperative Magnetic Resonance Imaging Use among Medicare Beneficiaries with Nonmetastatic Breast Cancer. Breast J, 22(1), 24-34.
  82. Williams J, Garvican L, Tosteson AN, Goodman DC, Onega T (2015). Breast cancer screening in England and the United States: a comparison of provision and utilisation. Int J Public Health, 60(8), 881-90.
  83. Liau A, Havidich JE, Onega T, Dutton RP (2015). The National Anesthesia Clinical Outcomes Registry. Anesth Analg, 121(6), 1604-10.
  84. Miglioretti DL, Zhu W, Kerlikowske K, Sprague BL, Onega T, Buist DS, Henderson LM, Smith RA, Breast Cancer Surveillance Consortium (2015). Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status. JAMA Oncol, 1(8), 1069-77.
  85. Lacson R, Harris K, Brawarsky P, Tosteson TD, Onega T, Tosteson AN, Kaye A, Gonzalez I, Birdwell R, Haas JS (2015). Evaluation of an Automated Information Extraction Tool for Imaging Data Elements to Populate a Breast Cancer Screening Registry. J Digit Imaging, 28(5), 567-75.
  86. Jackson SL, Abraham L, Miglioretti DL, Buist DS, Kerlikowske K, Onega T, Carney PA, Sickles EA, Elmore JG (2015). Patient and Radiologist Characteristics Associated With Accuracy of Two Types of Diagnostic Mammograms. AJR Am J Roentgenol, 205(2), 456-63.
  87. Johnson KC, Koestler DC, Fleischer T, Chen P, Jenson EG, Marotti JD, Onega T, Kristensen VN, Christensen BC (2015). DNA methylation in ductal carcinoma in situ related with future development of invasive breast cancer. Clin Epigenetics, 7, 75.
  88. Lee CI, Bogart A, Hubbard RA, Obadina ET, Hill DA, Haas JS, Tosteson AN, Alford-Teaster JA, Sprague BL, DeMartini WB, Lehman CD, Onega TL (2015). Advanced Breast Imaging Availability by Screening Facility Characteristics. Acad Radiol, 22(7), 846-52.
  89. Henderson LM, OMeara ES, Braithwaite D, Onega T, Breast Cancer Surveillance Consortium (2014). Performance of digital screening mammography among older women in the United States. Cancer, 121(9), 1379-86.
  90. Allison KH, Abraham LA, Weaver DL, Tosteson AN, Nelson HD, Onega T, Geller BM, Kerlikowske K, Carney PA, Ichikawa LE, Buist DS, Elmore JG (2015). Trends in breast biopsy pathology diagnoses among women undergoing mammography in the United States: a report from the Breast Cancer Surveillance Consortium. Cancer, 121(9), 1369-78.
  91. Shi X, Ayotte JD, Onda A, Miller S, Rees J, Gilbert-Diamond D, Onega T, Gui J, Karagas M, Moeschler J (2014). Geospatial association between adverse birth outcomes and arsenic in groundwater in New Hampshire, USA. Environ Geochem Health, 37(2), 333-51.
  92. Oster NV, Geller BM, Carney PA, Reisch LM, Onega T, Weaver DL, Frederick P, Elmore JG (2014). Demographic and practice characteristics of pathologists who enjoy breast tissue interpretation. Breast, 24(2), 107-11.
  93. Onega T, Baron JA, Johnsen SP, Pedersen L, Farkas DK, Srensen HT (2015). Cancer risk and subsequent survival after hospitalization for intermittent claudication. Cancer Epidemiol Biomarkers Prev, 24(4), 744-8.
  94. Elmore JG, Longton GM, Carney PA, Geller BM, Onega T, Tosteson AN, Nelson HD, Pepe MS, Allison KH, Schnitt SJ, OMalley FP, Weaver DL (2015). Diagnostic concordance among pathologists interpreting breast biopsy specimens. JAMA, 313(11), 1122-32.
  95. Hubbard RA, Zhu W, Balch S, Onega T, Fenton JJ (2014). Identification of abnormal screening mammogram interpretation using Medicare claims data. Health Serv Res, 50(1), 290-304.
  96. Hubbard RA, Benjamin-Johnson R, Onega T, Smith-Bindman R, Zhu W, Fenton JJ (2014). Classification accuracy of claims-based methods for identifying providers failing to meet performance targets. Stat Med, 34(1), 93-105.
  97. Onega T, Alford-Teaster J, Andrews S, Ganoe C, Perez M, David K, Shi X (2015). Why Health Services Research Needs Geoinformatics: Rationale and Case Example. J Health Med Informat, 5(6).
  98. Buist DS, Anderson ML, Smith RA, Carney PA, Miglioretti DL, Monsees BS, Sickles EA, Taplin SH, Geller BM, Yankaskas BC, Onega TL (2014). Effect of radiologists' diagnostic work-up volume on interpretive performance. Radiology, 273(2), 351-64.
  99. Geller BM, Nelson HD, Carney PA, Weaver DL, Onega T, Allison KH, Frederick PD, Tosteson AN, Elmore JG (2014). Second opinion in breast pathology: policy, practice and perception. J Clin Pathol, 67(11), 955-60.
  100. Kim CH, Lee YC, Hung RJ, McNallan SR, Cote ML, Lim WY, Chang SC, Kim JH, Ugolini D, Chen Y, Liloglou T, Andrew AS, Onega T, Duell EJ, Field JK, Lazarus P, Le Marchand L, Neri M, Vineis P, Kiyohara C, Hong YC, Morgenstern H, Matsuo K, Tajima K, Christiani DC, McLaughlin JR, Bencko V, Holcatova I, Boffetta P, Brennan P, Fabianova E, Foretova L, Janout V, Lissowska J, Mates D, Rudnai P, Szeszenia-Dabrowska N, Mukeria A, Zaridze D, Seow A, Schwartz AG, Yang P, Zhang ZF (2014). Exposure to secondhand tobacco smoke and lung cancer by histological type: a pooled analysis of the International Lung Cancer Consortium (ILCCO). Int J Cancer, 135(8), 1918-30.
  101. Onega T, Weaver D, Geller B, Oster N, Tosteson AN, Carney PA, Nelson H, Allison KH, OMalley FP, Schnitt SJ, Elmore JG (2014). Digitized whole slides for breast pathology interpretation: current practices and perceptions. J Digit Imaging, 27(5), 642-8.
  102. Onega T, Beaber EF, Sprague BL, Barlow WE, Haas JS, Tosteson AN, D Schnall M, Armstrong K, Schapira MM, Geller B, Weaver DL, Conant EF (2014). Breast cancer screening in an era of personalized regimens: a conceptual model and National Cancer Institute initiative for risk-based and preference-based approaches at a population level. Cancer, 120(19), 2955-64.
  103. Christiansen CF, Onega T, Svrke C, Krmendin Farkas D, Jespersen B, Baron JA, Srensen HT (2014). Risk and prognosis of cancer in patients with nephrotic syndrome. Am J Med, 127(9), 871-7.e1.
  104. Onega T, Hubbard R, Hill D, Lee CI, Haas JS, Carlos HA, Alford-Teaster J, Bogart A, DeMartini WB, Kerlikowske K, Virnig BA, Buist DS, Henderson L, Tosteson AN (2014). Geographic access to breast imaging for US women. J Am Coll Radiol, 11(9), 874-82.
  105. Onega T, Weiss J, Kerlikowske K, Wernli K, Buist DS, Henderson LM, Goodrich M, Alford-Teaster J, Virnig B, Tosteson AN, DeMartini W, Hubbard R (2014). The influence of race/ethnicity and place of service on breast reconstruction for Medicare beneficiaries with mastectomy. Springerplus, 3, 416.
  106. Feng S, Weaver DL, Carney PA, Reisch LM, Geller BM, Goodwin A, Rendi MH, Onega T, Allison KH, Tosteson AN, Nelson HD, Longton G, Pepe M, Elmore JG (2014). A framework for evaluating diagnostic discordance in pathology discovered during research studies. Arch Pathol Lab Med, 138(7), 955-61.
  107. Houssami N, Abraham LA, Onega T, Collins LC, Sprague BL, Hill DA, Miglioretti DL (2014). Accuracy of screening mammography in women with a history of lobular carcinoma in situ or atypical hyperplasia of the breast. Breast Cancer Res Treat, 145(3), 765-73.
  108. Geller BM, Bogart A, Carney PA, Sickles EA, Smith R, Monsees B, Bassett LW, Buist DM, Kerlikowske K, Onega T, Yankaskas BC, Haneuse S, Hill D, Wallis MG, Miglioretti D (2014). Educational interventions to improve screening mammography interpretation: a randomized controlled trial. AJR Am J Roentgenol, 202(6), W586-96.
  109. Bitton A, Onega T, Tosteson AN, Haas JS (2014). Toward a better understanding of patient-reported outcomes in clinical practice. Am J Manag Care, 20(4), 281-3.
  110. Butterly L, Robinson CM, Anderson JC, Weiss JE, Goodrich M, Onega TL, Amos CI, Beach ML (2014). Serrated and adenomatous polyp detection increases with longer withdrawal time: results from the New Hampshire Colonoscopy Registry. Am J Gastroenterol, 109(3), 417-26.
  111. Wernli KJ, DeMartini WB, Ichikawa L, Lehman CD, Onega T, Kerlikowske K, Henderson LM, Geller BM, Hofmann M, Yankaskas BC, Breast Cancer Surveillance Consortium (2013). Patterns of breast magnetic resonance imaging use in community practice. JAMA Intern Med, 174(1), 125-32.
  112. Wernli KJ, OMeara ES, Kerlikowske K, Miglioretti DL, Muller CY, Onega T, Sprague BL, Henderson LM, Buist DS (2013). Investigation of mammographic breast density as a risk factor for ovarian cancer. J Natl Cancer Inst, 106(1), djt341.
  113. Carney PA, Bogart A, Sickles EA, Smith R, Buist DS, Kerlikowske K, Onega T, Miglioretti DL, Rosenberg R, Yankaskas BC, Geller BM (2013). Feasibility and acceptability of conducting a randomized clinical trial designed to improve interpretation of screening mammography. Acad Radiol, 20(11), 1389-98.
  114. Schairer C, Li Y, Frawley P, Graubard BI, Wellman RD, Buist DS, Kerlikowske K, Onega TL, Anderson WF, Miglioretti DL (2013). Risk factors for inflammatory breast cancer and other invasive breast cancers. J Natl Cancer Inst, 105(18), 1373-84.
  115. Shi X, Miller S, Mwenda K, Onda A, Reese J, Onega T, Gui J, Karagas M, Demidenko E, Moeschler J (2013). Mapping disease at an approximated individual level using aggregate data: a case study of mapping New Hampshire birth defects. Int J Environ Res Public Health, 10(9), 4161-74.
  116. Onega T, Anderson ML, Miglioretti DL, Buist DS, Geller B, Bogart A, Smith RA, Sickles EA, Monsees B, Bassett L, Carney PA, Kerlikowske K, Yankaskas BC (2012). Establishing a gold standard for test sets: variation in interpretive agreement of expert mammographers. Acad Radiol, 20(6), 731-9.
  117. Hubbard RA, Zhu W, Horblyuk R, Karliner L, Sprague BL, Henderson L, Lee D, Onega T, Buist DS, Sweet A (2013). Diagnostic imaging and biopsy pathways following abnormal screen-film and digital screening mammography. Breast Cancer Res Treat, 138(3), 879-87.
  118. Hillner BE, Tosteson TD, Tosteson AN, Wang Q, Song Y, Onega T, Hanna LG, Siegel BA (2013). Intended versus inferred management after PET for cancer restaging: analysis of Medicare claims linked to a coverage with evidence development registry. Med Care, 51(4), 361-7.
  119. Harvey JA, Gard CC, Miglioretti DL, Yankaskas BC, Kerlikowske K, Buist DS, Geller BA, Onega TL, Breast Cancer Surveillance Consortium (2012). Reported mammographic density: film-screen versus digital acquisition. Radiology, 266(3), 752-8.
  120. Oster NV, Carney PA, Allison KH, Weaver DL, Reisch LM, Longton G, Onega T, Pepe M, Geller BM, Nelson HD, Ross TR, Tosteson AN, Elmore JG (2013). Development of a diagnostic test set to assess agreement in breast pathology: practical application of the Guidelines for Reporting Reliability and Agreement Studies (GRRAS). BMC Womens Health, 13, 3.
  121. Hubbard RA, Zhu W, Onega TL, Fishman P, Henderson LM, Tosteson AN, Buist DS (2012). Effects of digital mammography uptake on downstream breast-related care among older women. Med Care, 50(12), 1053-9.
  122. Davis MA, Onega T, Weeks WB, Lurie JD (2012). Where the United States spends its spine dollars: expenditures on different ambulatory services for the management of back and neck conditions. Spine, 37(19), 1693-701.
  123. Yasmeen S, Hubbard RA, Romano PS, Zhu W, Geller BM, Onega T, Yankaskas BC, Miglioretti DL, Kerlikowske K (2012). Risk of advanced-stage breast cancer among older women with comorbidities. Cancer Epidemiol Biomarkers Prev, 21(9), 1510-9.
  124. Cook AJ, Elmore JG, Zhu W, Jackson SL, Carney PA, Flowers C, Onega T, Geller B, Rosenberg RD, Miglioretti DL (2012). Mammographic interpretation: radiologists' ability to accurately estimate their performance and compare it with that of their peers. AJR Am J Roentgenol, 199(3), 695-702.
  125. Onega T, Tosteson TD, Wang Q, Hillner BE, Song Y, Siegel BA, Tosteson AN (2012). Geographic and sociodemographic disparities in PET use by Medicare beneficiaries with cancer. J Am Coll Radiol, 9(9), 635-42.
  126. Yim M, Butterly LF, Goodrich ME, Weiss JE, Onega TL (2011). Perception of colonoscopy benefits: a gap in patient knowledge? J Community Health, 37(3), 719-24.
  127. Buist DS, Walker R, Bowles EJ, Carney PA, Taplin SH, Onega T, Kerlikowske K, Clinton W, Miglioretti DL (2012). Screening mammography use among current, former, and never hormone therapy users may not explain recent declines in breast cancer incidence. Cancer Epidemiol Biomarkers Prev, 21(5), 720-7.
  128. Carney PA, Bogart TA, Geller BM, Haneuse S, Kerlikowske K, Buist DS, Smith R, Rosenberg R, Yankaskas BC, Onega T, Miglioretti DL (2012). Association between time spent interpreting, level of confidence, and accuracy of screening mammography. AJR Am J Roentgenol, 198(4), 970-8.
  129. Jackson SL, Cook AJ, Miglioretti DL, Carney PA, Geller BM, Onega T, Rosenberg RD, Brenner RJ, Elmore JG (2011). Are radiologists' goals for mammography accuracy consistent with published recommendations? Acad Radiol, 19(3), 289-95.
  130. Carney PA, Cook AJ, Miglioretti DL, Feig SA, Bowles EA, Geller BM, Kerlikowske K, Kettler M, Onega T, Elmore JG (2011). Use of clinical history affects accuracy of interpretive performance of screening mammography. J Clin Epidemiol, 65(2), 219-30.
  131. Schur EA, Elmore JE, Onega T, Wernli KJ, Sickles EA, Haneuse S (2011). The impact of obesity on follow-up after an abnormal screening mammogram. Cancer Epidemiol Biomarkers Prev, 21(2), 327-36.
  132. Lavoie Smith EM, Skalla K, Li Z, Onega T, Rhoda J, Gates C, Litterini A, Scott MR (2012). Assessing cancer survivors' needs using web-based technology: a pilot study. Comput Inform Nurs, 30(2), 71-81.
  133. Haneuse S, Buist DS, Miglioretti DL, Anderson ML, Carney PA, Onega T, Geller BM, Kerlikowske K, Rosenberg RD, Yankaskas BC, Elmore JG, Taplin SH, Smith RA, Sickles EA (2011). Mammographic interpretive volume and diagnostic mammogram interpretation performance in community practice. Radiology, 262(1), 69-79.
  134. Hillner BE, Tosteson AN, Song Y, Tosteson TD, Onega T, Goodman DC, Siegel BA (2011). Growth in the use of PET for six cancer types after coverage by medicare: additive or replacement? J Am Coll Radiol, 9(1), 33-41.
  135. Onega T, Weiss J, Diflorio R, Mackenzie T, Goodrich M, Poplack S (2012). Evaluating surveillance breast imaging and biopsy in older breast cancer survivors. Int J Breast Cancer, 2012, 347646.
  136. Demidenko E, Sargent J, Onega T (2013). Random effects coefficient of determination for mixed and meta-analysis models. Comm Stat Theor Meth, 41(6), 953-969.
  137. Sloan CD, Andrew AS, Gruber JF, Mwenda KM, Moore JH, Onega T, Karagas MR, Shi X, Duell EJ (2013). Indoor and Outdoor Air Pollution and Lung Cancer in New Hampshire and Vermont. Toxicol Environ Chem, 94(3).
  138. Onega T, Cook A, Kirlin B, Shi X, Alford-Teaster J, Tuzzio L, Buist DS (2011). The influence of travel time on breast cancer characteristics, receipt of primary therapy, and surveillance mammography. Breast Cancer Res Treat, 129(1), 269-75.
  139. Greene MA, Butterly LF, Goodrich M, Onega T, Baron JA, Lieberman DA, Dietrich AJ, Srivastava A (2011). Matching colonoscopy and pathology data in population-based registries: development of a novel algorithm and the initial experience of the New Hampshire Colonoscopy Registry. Gastrointest Endosc, 74(2), 334-40.
  140. Buist DS, Anderson ML, Haneuse SJ, Sickles EA, Smith RA, Carney PA, Taplin SH, Rosenberg RD, Geller BM, Onega TL, Monsees BS, Bassett LW, Yankaskas BC, Elmore JG, Kerlikowske K, Miglioretti DL (2011). Influence of annual interpretive volume on screening mammography performance in the United States. Radiology, 259(1), 72-84.
  141. Farhat GN, Walker R, Buist DS, Onega T, Kerlikowske K (2010). Changes in invasive breast cancer and ductal carcinoma in situ rates in relation to the decline in hormone therapy use. J Clin Oncol, 28(35), 5140-6.
  142. DeMartini WB, Ichikawa L, Yankaskas BC, Buist D, Kerlikowske K, Geller B, Onega T, Rosenberg RD, Lehman CD (2010). Breast MRI in community practice: equipment and imaging techniques at facilities in the Breast Cancer Surveillance Consortium. J Am Coll Radiol, 7(11), 878-84.
  143. Onega T, Aiello Bowles EJ, Miglioretti DL, Carney PA, Geller BM, Yankaskas BC, Kerlikowske K, Sickles EA, Elmore JG (2010). Radiologists' perceptions of computer aided detection versus double reading for mammography interpretation. Acad Radiol, 17(10), 1217-26.
  144. Onega T, Duell EJ, Shi X, Demidenko E, Goodman DC (2010). Race versus place of service in mortality among medicare beneficiaries with cancer. Cancer, 116(11), 2698-706.
  145. Elmore JG, Aiello Bowles EJ, Geller B, Oster NV, Carney PA, Miglioretti DL, Buist DS, Kerlikowske K, Sickles EA, Onega T, Rosenberg RD, Yankaskas BC (2009). Radiologists' attitudes and use of mammography audit reports. Acad Radiol, 17(6), 752-60.
  146. Celaya MO, Berke EM, Onega TL, Gui J, Riddle BL, Cherala SS, Rees JR (2010). Breast cancer stage at diagnosis and geographic access to mammography screening (New Hampshire, 1998-2004). Rural Remote Health, 10(2), 1361.
  147. Butterly LF, Goodrich M, Onega T, Greene MA, Srivastava A, Burt R, Dietrich A (2009). Improving the quality of colorectal cancer screening: assessment of familial risk. Dig Dis Sci, 55(3), 754-60.
  148. Onega T, MacKenzie T, Weiss J, Goodrich M, Titus-Ernstoff L (2009). Screening mammography intervals among postmenopausal hormone therapy users and nonusers. Cancer Causes Control, 21(1), 147-52.
  149. Onega T, Goodrich M, Dietrich A, Butterly L (2010). The influence of smoking, gender, and family history on colorectal adenomas. J Cancer Epidemiol, 2010, 509347.
  150. Gibson CJ, Weiss J, Goodrich M, Onega T (2009). False-positive mammography and depressed mood in a screening population: findings from the New Hampshire Mammography Network. J Public Health (Oxf), 31(4), 554-60.
  151. Miglioretti DL, Gard CC, Carney PA, Onega TL, Buist DS, Sickles EA, Kerlikowske K, Rosenberg RD, Yankaskas BC, Geller BM, Elmore JG (2009). When radiologists perform best: the learning curve in screening mammogram interpretation. Radiology, 253(3), 632-40.
  152. Elmore JG, Jackson SL, Abraham L, Miglioretti DL, Carney PA, Geller BM, Yankaskas BC, Kerlikowske K, Onega T, Rosenberg RD, Sickles EA, Buist DS (2009). Variability in interpretive performance at screening mammography and radiologists' characteristics associated with accuracy. Radiology, 253(3), 641-51.
  153. Gallagher TH, Cook AJ, Brenner RJ, Carney PA, Miglioretti DL, Geller BM, Kerlikowske K, Onega TL, Rosenberg RD, Yankaskas BC, Lehman CD, Elmore JG (2009). Disclosing harmful mammography errors to patients. Radiology, 253(2), 443-52.
  154. Heck JE, Andrew AS, Onega T, Rigas JR, Jackson BP, Karagas MR, Duell EJ (2009). Lung cancer in a U.S. population with low to moderate arsenic exposure. Environ Health Perspect, 117(11), 1718-23.
  155. Onega T, Duell EJ, Shi X, Demidenko E, Gottlieb D, Goodman DC (2009). Influence of NCI cancer center attendance on mortality in lung, breast, colorectal, and prostate cancer patients. Med Care Res Rev, 66(5), 542-60.
  156. Cronin KA, Miglioretti DL, Krapcho M, Yu B, Geller BM, Carney PA, Onega T, Feuer EJ, Breen N, Ballard-Barbash R (2009). Bias associated with self-report of prior screening mammography. Cancer Epidemiol Biomarkers Prev, 18(6), 1699-705.
  157. Onega T, Duell EJ, Shi X, Demidenko E, Goodman D (2008). Determinants of NCI Cancer Center attendance in Medicare patients with lung, breast, colorectal, or prostate cancer. J Gen Intern Med, 24(2), 205-10.
  158. Onega T, Duell EJ, Shi X, Wang D, Demidenko E, Goodman D (2008). Geographic access to cancer care in the U.S. Cancer, 112(4), 909-18.
  159. Shi X, Duell E, Demidenko E, Onega T, Wilson B, Hoftiezer D (2007). A polygon-based locally-weighted-average method for smoothing disease rates of small units. Epidemiology, 18(5), 523-8.
  160. Onega T, Baron J, MacKenzie T (2006). Cancer after total joint arthroplasty: a meta-analysis. Cancer Epidemiol Biomarkers Prev, 15(8), 1532-7.
  161. Onega T (2005). Diagnosing the acute scrotum. The accuracy of clinical assessment and bedside US compared with the gold standard. JAAPA, 17(12), 40-2.
  162. Onega T (2004). Does a low-carbohydrate diet affect biomarkers for CVD? JAAPA, 17(4), 44-6.
  163. Onega T (2002). Saw palmetto for BPH: a review of a meta-analysis. JAAPA, 15(5), 59-60, 63-4.
  164. Onega T (2001). Clinic: critically appraised topics. Ectopic pregnancy evaluating first-line diagnostic tools. JAAPA, 14(8), 21-4.
  165. Onega T (2001). Sorting out the common anemias. JAAPA, 13(9), 30-2, 35-6, 39-44 passim.
  166. Onega T (2001). How does menopause alter the primary care of women? JAAPA, 13(4), 42-4, 47-8, 51-4 passim.
  167. Bagby GC Jr, Segal GM, Auerbach AD, Onega T, Keeble W, Heinrich MC (1993). Constitutive and induced expression of hematopoietic growth factor genes by fibroblasts from children with Fanconi anemia. Exp Hematol, 21(11), 1419-26.